Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?
11/7 14:19
MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio....
|
|
|
11/7 14:19
MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio....